# Suprathel Versus Xeroform for the Management of Skin Graft Donor Sites

> **NCT04014400** · NA · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 10 (actual)

## Conditions studied

- Burns
- Skin Graft Complications
- Skin; Deformity

## Interventions

- **OTHER:** Suprathel or Xeroform donor site application

## Key facts

- **NCT ID:** NCT04014400
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-07
- **Primary completion:** 2020-07-23
- **Final completion:** 2020-07-23
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** We observed that using the Suprathel dressing required additional treatment of the wound and had a longer healing time than the standard of care Xeroform dressing; it did not dry the wound out properly to promote healing.
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04014400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04014400, "Suprathel Versus Xeroform for the Management of Skin Graft Donor Sites". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04014400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*